Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hyperinsulinemia: early-phase trial registry
4 of 6 indexed Hyperinsulinemia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Hyperinsulinemia: 6 US clinical trials tracked, 4 recruiting.
Hyperinsulinemia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 2 of these trials.
Enrollment posture brief
Registry condition hyperinsulinemia
OPEN 4 | RECR 67% | LATE 0 | EARLY 2 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Hyperinsulinemia lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hyperinsulinemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hyperinsulinemia is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hyperinsulinemia research.
Columbia University accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Hyperinsulinemia trials plan to enrol fewer than 100 people.
Median target enrolment is 15 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Hyperinsulinemia splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT03374215
Graded Insulin Suppression Test P&F
Columbia University
NCT06592261
Diazoxide Suppression Test P&F Study
Columbia University
NCT06606327
The Movie Theater Study
Ball State University
NCT06444984
Reprometabolic Syndrome Mediates Subfertility in Obesity
University of Colorado, Denver
NCT02653092
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia
Henry Ford Health System
NCT01125150
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Hyperinsulinemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hyperinsulinemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hyperinsulinemia page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Hyperinsulinemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Columbia University sponsors the most Hyperinsulinemia trials on record, review their full trial history before evaluating a specific study. See Columbia University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hyperinsulinemia condition card totals 6 registered trials; most-linked intervention Dietary Modification; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.